Laetitia Szaller

General Counsel and Head of Compliance at Egetis Therapeutics

Speaker

Laetitia brings over two decades of diverse experience spanning various industries, with a commendable 17 years dedicated to the pharmaceutical and medical device sector. Her expertise extends to steering and overseeing intricate multi-jurisdictional operations, including the orchestration of global multimillion-dollar M&A transactions, licensing agreements, and collaborative partnerships.

In her current role at Egetis Therapeutics, where she assumed responsibilities in December 2023, Laetitia manages the global legal and compliance functions, preparing the organization for launch in Europe and the US. She is also heading the enterprise risk management and ESG function across international markets.

Prior to this, she played a pivotal role in the Legal operations and Corporate Development at AM-Pharma, preparing for the company's IPO readiness and commercialization including the negotiation of a significant Japanese out-licensing agreement.

Her professional journey also includes significant contributions at UCB as the global Associate General Counsel for BD, M&A, and Antitrust, where she led global multi-million projects in asset divestment, licensing, and venture funds investment, while heading the Belgian R&D site's legal operations. Her outstanding performance earned her recognition as Top Talent with three awards.

She represented AM-Pharma and UCB at EFPIA in Brussels, actively contributing to EU policymaking.